Barry E. Greene elected to Dyne Therapeutics board; receives option for 57,463 shares

Dyne Therapeutics, Inc.

Elected as Class I director effective June 22, 2026, to serve until 2027 annual meeting.
Received option for 57,463 shares at $20.87 per share, vesting monthly over 3 years.
Will receive $45,000 annual cash retainer and standard equity grants per non-employee director program.
No committee appointments; board determined independent per Nasdaq rules.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Barry E. Greene

Class I director

DYN · Dyne Therapeutics, Inc.

Effective: 2026-06-22
Filed: June 22, 2026, 4:15 PM ET

On June 22, 2026, the Board of Directors (the “Board”) of Dyne Therapeutics, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Barry E. Greene as a Class I director to serve on the Board until the Company’s 2027 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barry E. Greene was elected as Class I director at Dyne Therapeutics, Inc..

Action: elected
Role: Class I director

Exact text from the filing

On June 22, 2026, the Board of Directors (the “Board”) of Dyne Therapeutics, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Barry E. Greene as a Class I director to serve on the Board until the Company’s 2027 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.

View on SEC.gov

Dyne Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001818794-26-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.